Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/22784
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDi Giovanni, Giuseppe-
dc.contributor.authorEsposito, Ennio-
dc.contributor.authorDi Matteo, Vincenzo-
dc.date.accessioned2017-10-17T14:03:29Z-
dc.date.available2017-10-17T14:03:29Z-
dc.date.issued2010-
dc.identifier.citationDi Giovanni, G., Esposito, E., & Di Matteo, V. (2010). Role of serotonin in central dopamine dysfunction. CNS Neuroscience & Therapeutics. 16(3), 179-194.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar//handle/123456789/22784-
dc.description.abstractThe interaction between serotonin (5-HT) and dopamine (DA)-containing neurons in the brain is a research topic that has raised the interest of many scientists working in the field of neuroscience since the first demonstration of the presence of monoamine-containing neurons in the mid 1960. The bulk of neuroanatomical data available clearly indicate that DA-containing neurons in the brain receive a prominent innervation from serotonin (5-hydroxytryptamine, 5-HT) originating in the raphe nuclei of the brainstem. Compelling electrophysiological and neurochemical data show that 5-HT can exert complex effects on the activity of midbrain DA neurons mediated by its various receptor subtypes. The main control seems to be inhibitory, this effect being more marked in the mesocorticolimbic DA system as compared to the DA nigrostriatal system. In spite of a direct effect of 5-HT by its receptors located on DA cells, 5-HT can modulate their activity indirectly, modifying γ-aminobutyric (GABA)-ergic and glutamatergic input to the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc). Although 5-HT/DA interaction in the brain has been extensively studied, much work remains to be done to clarify this issue. The recent development of subtype-selective ligands for 5-HT receptors will not only allow a detailed understanding of this interaction but also will lead to the development of new treatment strategies, appropriate for those neuropsychiatric disorders in which an alteration of the 5-HT/DA balance is supposed.en_GB
dc.language.isoenen_GB
dc.publisherWiley-Blackwell Publishing Ltd.en_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectAntidepressantsen_GB
dc.subjectReceptor, Serotonin, 5-HTen_GB
dc.subjectParkinson's diseaseen_GB
dc.subjectAntipsychotic drugsen_GB
dc.subjectBrain microdialysisen_GB
dc.titleRole of serotonin in central dopamine dysfunctionen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.1111/j.1755-5949.2010.00135.x-
dc.publication.titleCNS Neuroscience & Therapeuticsen_GB
Appears in Collections:Scholarly Works - FacM&SPB

Files in This Item:
File Description SizeFormat 
Role_of_Serotonin_in_Central_Dopamine_Dysfunction.pdf262.33 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.